Dr. Xue will lead a virtual symposium on “Leveraging Existing Data from CMS-Linked Cohort Studies for the Advancement and Translation of Frailty Research” at the 2020 Annual Meeting of the Gerontological Society of America.
Dr. Xue led a symposium on “Latest Advances in Understanding the Relationships between Frailty and Cognitive Impairment” at the 2019 Annual Meeting of the Gerontological Society of America.
Dr. Walston presented a keynote presentation on “Biomarkers and the Biology of Frailty” at the 2019 International Conference on Frailty and Sarcopenia Research.
Dr. Bandeen-Roche led a symposium on: The Gap between Theory and Practice: A 360 Degree Consideration of Opportunities Remaining in Frailty Measurement” at the 2019 International Conference on Frailty and Sarcopenia Research.
Dr. Walston led a symposium on “Metabolomic Signatures of Frailty” at the 2018 International Conference on Frailty and Sarcopenia Research in Miami.
Dr. Bandeen-Roche led a symposium on “Disparities in Frailty and Resiliency among Older Adults” at the 2018 Annual Meeting of the Gerontological Society of America in Boston.
Dr. Walston led a symposium, entitled “The Molecular and Organismal Basis of Resilience and Frailty” at the 21st IAGG World Congress of Gerontology and Geriatrics in San Francisco in July 2017.
Drs. Bandeen-Roche and Xue co-led, with Dr. Luigi Ferrucci, a symposium on “New Developments in Frailty Construct Validation: Move Beyond Predictive Validity,” at the 2016 Annual Meeting of the Gerontological Society of American in New Orleans, LA on November 17, 2016.
Dr. Walston led a symposium on “A Mouse Model of Chronic Inflammation, Sarcopenia and Phenotypic Frailty,” at the 2016 International Conference on Frailty and Sarcopenia Research in Philadelphia PA on April 28, 2016.
“Disparities in Physical Functioning and Frailty among Older Americans: Findings from the NHATS,” at the 2015 Annual Meeting of the Gerontological Society of American in Orlando, FL on November 21, 2015.
“Intersection and distinction between physical frailty and cognitive impairments among older adults” at the 2015 International Conference on Frailty and Sarcopenia Research in Boston in April 2015.
“Should Cognition be Included in the Assessment of Frailty?” at the 2014 Annual Meeting of the Gerontological Society of American in Washington, D.C. on November 8, 2014.
“Towards the Integration of Frailty into Clinical Practice,” at the 2014 Annual Meeting of The American Geriatrics Society in Orlando, FL on May 15, 2014.
“Beyond Epidemiological Risk Assessment: Frailty Syndrome Identification as the Key for Clinical Management, Biological Discovery, and Intervention Development” at the 2014 International Conference on Frailty and Sarcopenia Research in Barcelona, Spain in March 2014.
2014 Annual Meeting of the American Geriatrics Society, May 2014
2014 International Conference on Frailty and Sarcopenia Research, March 2014
“From Biology to Clinical Phenotype: Latest Findings in the Evolution of Frailty Research” at the 2013 Annual Meeting of the Gerontological Society of America in New Orleans
2013 Annual Meeting of the Gerontological Society of America, November 2013